Xinjun Hou

机构：Pfizer (United States), PRX Research · ORCID：0000-0002-3473-8455

发表论文 84 篇 · 总被引 5124 次 · h-index 33

代表论文

• Current and Future Roles of Artificial Intelligence in Medicinal Chemistry Synthesis (2020 · Journal of Medicinal Chemistry · 被引 258)
• Validation of Human MDR1-MDCK and BCRP-MDCK Cell Lines to Improve the Prediction of Brain Penetration (2019 · Journal of Pharmaceutical Sciences · 被引 104)
• Probing the chemical ‘reactome’ with high-throughput experimentation data (2024 · Nature Chemistry · 被引 49)
• Optimal designs for pairwise calculation: An application to free energy perturbation in minimizing prediction variability (2019 · Journal of Computational Chemistry · 被引 35)
• Development and Comprehensive Benchmark of a High-Quality AMBER-Consistent Small Molecule Force Field with Broad Chemical Space Coverage for Molecular Modeling and Free Energy Calculation (2023 · Journal of Chemical Theory and Computation · 被引 18)
• Harnessing Preclinical Data as a Predictive Tool for Human Brain Tissue Targeting (2021 · ACS Chemical Neuroscience · 被引 18)